XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
136 hedge funds and large institutions have $1.02B invested in Acceleron Pharma in 2016 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 54 increasing their positions, 35 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
6% more funds holding
Funds holding: 128 → 136 (+8)
80% less call options, than puts
Call options by funds: $870K | Put options by funds: $4.28M
Holders
136
Holding in Top 10
4
Calls
$870K
Puts
$4.28M
Top Buyers
| 1 | +$21.9M | |
| 2 | +$16.8M | |
| 3 | +$8.45M | |
| 4 |
Goldman Sachs
New York
|
+$6.78M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$6.7M |
Top Sellers
| 1 | -$31.1M | |
| 2 | -$9.33M | |
| 3 | -$6.8M | |
| 4 |
ORI
Oak Ridge Investments
Chicago,
Illinois
|
-$5.57M |
| 5 |
FCMI
Foresite Capital Management II
Larkspur,
California
|
-$4.26M |